diazoxide for the treatment of ataxia of friedreich

摘要

The present invention concerns a pharmaceutical preparation for the treatment of Friedreich's ataxia and for the treatment or prevention of pathologies related thereto. Particularly the present invention concerns the use of diazoxide or 7-chloro-3-methyl - 4H -1,2,4 benzothiadiazine 1,1-dioxide, in combination with glucose and/or leucine, for the treatment of Friedreich's ataxia (FRDA) and for the treatment or prevention of pathologies related thereto.